About OPTIMIZERx Corp
Ticker
info
OPRX
Trading on
info
NASDAQ
ISIN
info
US68401U2042
Industry
info
Health Information Services
Sector
info
Healthcare
CEO
info
Stephen L. Silvestro
Headquarters
info
260 Charles Street, Waltham, MA, United States, 02453
Employees
info
128
Website
info
optimizerx.com
OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. It also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is based in Waltham, Massachusetts.
Metrics
BasicAdvanced
Market cap
info
$264M
P/E ratio
info
-
EPS
info
-$0.84
Dividend Yield
info
0.00%
Beta
info
1.33
Forward P/E ratio
info
25.97
EBIDTA
info
$1M
Ex dividend date
info
-
Price & volume
Market cap
info
$264M
Average daily volume
info
0.4M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
25.97
PEG ratio
info
1.61
Trailing P/E
info
0
Price to sales
info
2.8
Price to book
info
2.39
Earnings
EPS
info
-$0.84
EPS estimate (current quarter)
info
-$0.12
EPS estimate (next quarter)
info
-$0.02
EBITDA
info
$1M
Revenues (TTM)
info
$94.4M
Revenues per share (TTM)
info
$5.14
Technicals
Beta
info
1.33
52-week High
info
$15.71
52-week Low
info
$3.78
50-day moving average
info
$10.48
200-day moving average
info
$7.25
Short ratio
info
4.84
Short %
info
8.85%
Management effectiveness
ROE (TTM)
info
-12.91%
ROA (TTM)
info
-1.20%
Profit margin
info
-16.33%
Gross profit margin
info
$60.5M
Operating margin
info
-9.64%
Growth
Quarterly earnings growth (YoY)
info
-66.80%
Quarterly revenue growth (YoY)
info
11.40%
Share stats
Outstanding Shares
info
18.5M
Float
info
14.3M
Insiders %
info
7.23%
Institutions %
info
66.27%
Analyst Insights & forecasts
info

86% Buy

14% Hold

0% Sell

Based on information from 7 analysts.

Average price target

info
$15.67
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.02
-$0.06
133.33%
Q2 • 24Beat
$0.12
$0.06
100.00%
Q3 • 24Beat
$0.30
$0.38
-20.80%
Q4 • 24Missed
$0.08
-$0.13
161.54%
Q1 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$32.3M
$-0.1M
-0.24%
Q4 • 24
$21.9M
$-2.2M
-10.03%
Q1 • 25
-32.15%
2,755.84%
4,108.75%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$171M
$54.2M
31.65%
Q4 • 24
$168M
$51.5M
30.70%
Q1 • 25
-1.99%
-4.93%
-3.01%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$0.2M
$-0.1M
$-2.8M
$0.1M
Q4 • 24
$3.9M
$-0.1M
$-0.6M
$3.8M
Q1 • 25
1,851.52%
-30.00%
-79.21%
4,819.23%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a OPTIMIZERx Corp share?
Collapse

OPTIMIZERx Corp shares are currently traded for undefined per share.

How many shares does OPTIMIZERx Corp have?
Collapse

OPTIMIZERx Corp currently has 18.5M shares.

Does OPTIMIZERx Corp pay dividends?
Collapse

No, OPTIMIZERx Corp doesn't pay dividends.

What is OPTIMIZERx Corp 52 week high?
Collapse

OPTIMIZERx Corp 52 week high is $15.71.

What is OPTIMIZERx Corp 52 week low?
Collapse

OPTIMIZERx Corp 52 week low is $3.78.

What is the 200-day moving average of OPTIMIZERx Corp?
Collapse

OPTIMIZERx Corp 200-day moving average is $7.25.

Who is OPTIMIZERx Corp CEO?
Collapse

The CEO of OPTIMIZERx Corp is Stephen L. Silvestro.

How many employees OPTIMIZERx Corp has?
Collapse

OPTIMIZERx Corp has 128 employees.

What is the market cap of OPTIMIZERx Corp?
Collapse

The market cap of OPTIMIZERx Corp is $264M.

What is the P/E of OPTIMIZERx Corp?
Collapse

The current P/E of OPTIMIZERx Corp is null.

What is the EPS of OPTIMIZERx Corp?
Collapse

The EPS of OPTIMIZERx Corp is -$0.84.

What is the PEG Ratio of OPTIMIZERx Corp?
Collapse

The PEG Ratio of OPTIMIZERx Corp is 1.61.

What do analysts say about OPTIMIZERx Corp?
Collapse

According to the analysts OPTIMIZERx Corp is considered a buy.